Magna-Lab nabs distribution deal
Magna-Lab has added to its stableof distribution partners by signing a deal this month with BetaNumerics for global sales and marketing of the company's Magna-SL0.3-tesla extremity scanner. The deal complements a similar agreementreached with Elscint
Magna-Lab has added to its stableof distribution partners by signing a deal this month with BetaNumerics for global sales and marketing of the company's Magna-SL0.3-tesla extremity scanner. The deal complements a similar agreementreached with Elscint (SCAN 12/14/94).
Beta Numerics, of Canandaigua, NY, was formed recently to placemedical equipment at clinical sites on a fee-for-service basis.Its management team is headed by chairman Coy Eklund, formerlychairman of Equitable Life Assurance Society, and medical imagingveteran John Roberts, who serves as president.
Under the agreement between the firms, Beta Numerics will handledistribution of Magna-SL in Japan, India, Mexico, Singapore andGreece. These territories are not covered by Magna-Lab's Elscintdeal.
In addition, Beta Numerics has exclusive worldwide rights tofee-for-service placements of Magna-SL. Beta Numerics will alsohave worldwide distribution rights to a mobile version of Magna-SLin return for funding development of the scanner, according toMagna-Lab president John Haytaian.
As part of the agreement, Beta Numerics advanced $400,000 toMagna-Lab as payment for the first delivery of a Magna-SL system,which is being placed in aSan Antonio hospital on a fee-for-servicebasis.
The 10-year agreement requires minimum purchases by Beta Numericsof eight scanners in 1995, 16 scanners in the second year and24 scanners a year in the third through the tenth year. If theminimum targets are met, the deal would be worth $80 million toMagna-Lab.
In other Magna-Lab news, the Hicksville, NY, company met withrepresentatives from the NASDAQ stock exchange on Dec. 15 to discussthe firm's listing. NASDAQ informed Magna-Lab in November thatit may be out of compliance with NASDAQ listing requirements basedon the company's second-quarter results.
The meeting with NASDAQ went well and Magna-Lab believes thatit will maintain its listing, according to Haytaian. Magna-Labexpects to get final word on NASDAQ's decision by the middle ofJanuary.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.
